Hematologist Encounters Among Medicaid Patients Who Have Sickle Cell Disease

Overview

Journal Blood Adv

Specialty Hematology

Date 2022 Jul 12

PMID 35819456

Authors

Sophia S Horiuchi

Mei Zhou

Angela Snyder

Susan T Paulukonis

Affiliations

Soon will be listed here.

Citing Articles

Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study.

Valle J, Lebensburger J, Garimella P, Gopal S JMIR Public Health Surveill. 2024; 10:e57290.

PMID: 39008353 PMC: 11287091. DOI: 10.2196/57290.

Medicaid Coverage in Early Childhood for Children With Sickle Cell Disease.

Horiuchi S, Reeves S, Plaxco A, Peng H, Zhou M, Kayle M JAMA Netw Open. 2024; 7(7):e2421491.

PMID: 38995648 PMC: 11245719. DOI: 10.1001/jamanetworkopen.2024.21491.

National Quality Indicators in Pediatric Sickle Cell Anemia.

Anderson A, Mack W, Horiuchi S, Paulukonis S, Zhou M, Snyder A Pediatrics. 2024; 153(4).

PMID: 38444343 PMC: 10982541. DOI: 10.1542/peds.2022-060804.

Family planning needs of young adults with sickle cell disease.

Linton E, Williams E, Early M, Prince E, Stewart R, Lanzkron S EJHaem. 2023; 4(3):587-594.

PMID: 37601884 PMC: 10435671. DOI: 10.1002/jha2.711.

References

Paulukonis S, Harris W, Coates T, Neumayr L, Treadwell M, Vichinsky E . Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH). Pediatr Blood Cancer. 2014; 61(12):2271-6. DOI: 10.1002/pbc.25208. View

Okpala I, Thomas V, Westerdale N, Jegede T, Raj K, Daley S . The comprehensiveness care of sickle cell disease. Eur J Haematol. 2002; 68(3):157-62. DOI: 10.1034/j.1600-0609.2002.01523.x. View

Koch K, Karafin M, Simpson P, Field J . Intensive management of high-utilizing adults with sickle cell disease lowers admissions. Am J Hematol. 2014; 90(3):215-9. DOI: 10.1002/ajh.23912. View

Basishvili G, Gotesman J, Vandervoort K, Jacobs C, Vattappally L, Minniti C . Comprehensive management reduces incidence and mortality of acute chest syndrome in patients with sickle cell disease. Am J Hematol. 2017; 93(3):E64-E67. DOI: 10.1002/ajh.24994. View

Grosse S, Schechter M, Kulkarni R, Lloyd-Puryear M, Strickland B, Trevathan E . Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders. Pediatrics. 2009; 123(1):407-12. DOI: 10.1542/peds.2007-2875. View

Sobota A, Neufeld E, Sprinz P, Heeney M . Transition from pediatric to adult care for sickle cell disease: results of a survey of pediatric providers. Am J Hematol. 2011; 86(6):512-5. PMC: 5804481. DOI: 10.1002/ajh.22016. View

Quinn C, Rogers Z, McCavit T, Buchanan G . Improved survival of children and adolescents with sickle cell disease. Blood. 2010; 115(17):3447-52. PMC: 2867259. DOI: 10.1182/blood-2009-07-233700. View

Okolo A, Michael Soucie J, Grosse S, Roberson C, Janson I, Allen M . Population-based surveillance of haemophilia and patient outcomes in Indiana using multiple data sources. Haemophilia. 2019; 25(3):456-462. PMC: 6850020. DOI: 10.1111/hae.13734. View

Bindman A . Using the National Provider Identifier for health care workforce evaluation. Medicare Medicaid Res Rev. 2014; 3(3). PMC: 3983736. DOI: 10.5600/mmrr.003.03.b03. View

10.

Kanter J, Smith W, Desai P, Treadwell M, Andemariam B, Little J . Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects. Blood Adv. 2020; 4(16):3804-3813. PMC: 7448595. DOI: 10.1182/bloodadvances.2020001743. View

11.

Snyder A, Zhou M, Theodore R, Quarmyne M, Eckman J, Lane P . Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell Disease. Public Health Rep. 2019; 134(3):274-281. PMC: 6505322. DOI: 10.1177/0033354919839072. View

12.

Yang Y, Shah A, Watson M, Mankad V . Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Public Health Rep. 1995; 110(1):80-6. PMC: 1382078. View

13.

Power-Hays A, McGann P . When Actions Speak Louder Than Words - Racism and Sickle Cell Disease. N Engl J Med. 2020; 383(20):1902-1903. DOI: 10.1056/NEJMp2022125. View

14.

Blinder M, Vekeman F, Sasane M, Trahey A, Paley C, Duh M . Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Pediatr Blood Cancer. 2013; 60(5):828-35. DOI: 10.1002/pbc.24459. View

15.

Lanzkron S, Carroll C, Hill P, David M, Paul N, Haywood Jr C . Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis. Am J Hematol. 2015; 90(5):376-80. PMC: 4409504. DOI: 10.1002/ajh.23961. View

16.

Brousseau D, Panepinto J, Nimmer M, Hoffmann R . The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol. 2009; 85(1):77-8. DOI: 10.1002/ajh.21570. View

17.

Kanter J, Meier E, Hankins J, Paulukonis S, Snyder A . Improving Outcomes for Patients With Sickle Cell Disease in the United States: Making the Case for More Resources, Surveillance, and Longitudinal Data. JAMA Health Forum. 2022; 2(10):e213467. DOI: 10.1001/jamahealthforum.2021.3467. View

18.

Hulihan M, Feuchtbaum L, Jordan L, Kirby R, Snyder A, Young W . State-based surveillance for selected hemoglobinopathies. Genet Med. 2014; 17(2):125-30. PMC: 4427044. DOI: 10.1038/gim.2014.81. View

19.

Lee L, Smith-Whitley K, Banks S, Puckrein G . Reducing Health Care Disparities in Sickle Cell Disease: A Review. Public Health Rep. 2019; 134(6):599-607. PMC: 6832089. DOI: 10.1177/0033354919881438. View

20.

Crego N, Douglas C, Bonnabeau E, Earls M, Eason K, Merwin E . Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use. J Am Board Fam Med. 2020; 33(1):91-105. PMC: 7942752. DOI: 10.3122/jabfm.2020.01.190143. View